Related Experiment Video

Updated: Jul 1, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy

Baojie Li1

  • 1Cancer and Developmental Cell Biology Division, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore. libj@imcb.a-star.edu.sg

Endocrine, Metabolic & Immune Disorders Drug Targets
|September 11, 2008
PubMed

Insights

Bone morphogenetic proteins (BMPs) activate the BMP-Smad pathway, crucial for bone health and development. This pathway

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Developmental Biology

Background:

  • Bone morphogenetic proteins (BMPs) are key signaling molecules in the transforming growth factor-beta (TGF-beta) superfamily.
  • BMPs initiate intracellular signaling cascades via cell surface receptors, leading to the phosphorylation of Smad proteins (Smad1/5/8).

Purpose of the Study:

  • To elucidate the fundamental roles of the BMP-Smad signaling pathway in biological processes.
  • To explore the implications of BMP-Smad signaling in bone homeostasis and tumorigenesis.

Main Methods:

  • The study integrates findings from human and mouse genetic research.
  • Analysis of BMP-Smad pathway components and their downstream transcriptional targets.

Main Results:

  • BMP-Smad signaling is essential for regulating stem cell functions, cell proliferation, differentiation, migration, and apoptosis.
  • Genetic studies confirm BMPs' positive impact on postnatal bone homeostasis, including osteoblast activity and bone formation.
  • Evidence suggests BMP-Smad signaling exhibits tumor-suppressive activity in various tissues, inhibiting tumor growth.

Conclusions:

  • Dysregulation of BMP-Smad signaling is implicated in bone disorders like osteoporosis.
  • The BMP-Smad pathway presents a promising therapeutic target for both osteoporosis and cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...